LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

LLY

1,037

+2.17%↑

JNJ

244.47

+1.48%↑

ABBV

227.53

+3.09%↑

NVS

160.86

+0.83%↑

MRK

119.17

-0.13%↓

Search

Odonate Therapeutics Inc

Închisă

0

Rezumat

Modificarea prețului

24h

Curent

Minim

Maxim

Indicatori cheie

By Trading Economics

Odonate Therapeutics Inc Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 feb. 2026, 23:57 UTC

Acțiuni populare

Stocks to Watch: Applied Materials, Arista, DraftKings, Pinterest

12 feb. 2026, 23:35 UTC

Câștiguri
Principalele dinamici ale pieței

Arista Networks Surges on AI Networking Demand, Despite Rising Costs

12 feb. 2026, 23:28 UTC

Câștiguri

Applied Materials Profit Rises on Soaring AI Demand -- Update

12 feb. 2026, 21:47 UTC

Câștiguri

Vertex Pharmaceuticals Revenue Climbs on Continued Cystic Fibrosis Demand

13 feb. 2026, 00:00 UTC

Market Talk

ANZ Gets a New Bull as Productivity Prospects Improve -- Market Talk

12 feb. 2026, 23:47 UTC

Market Talk

Nikkei May Fall After AI Concerns Drag Stocks on Wall Street -- Market Talk

12 feb. 2026, 23:38 UTC

Market Talk

Gold Steady; Could Undergo Technical Recovery -- Market Talk

12 feb. 2026, 23:33 UTC

Câștiguri

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- 2nd Update

12 feb. 2026, 23:09 UTC

Market Talk

South32's Hermosa Review Stokes Spending Fears -- Market Talk

12 feb. 2026, 22:55 UTC

Câștiguri
Acțiuni populare

Applied Materials, DraftKings, Airbnb: Earnings in Focus -- WSJ

12 feb. 2026, 22:46 UTC

Market Talk

Northern Star Outlook Needs Project Done On Time, In Budget -- Market Talk

12 feb. 2026, 22:23 UTC

Câștiguri

Coinbase Swings to a Fourth-Quarter Loss Amid Crypto Meltdown -- Update

12 feb. 2026, 22:15 UTC

Câștiguri

Agnico-Eagle Mines: Gold Production for 2026 and 2027, Expected at 3.3M to 3.5M Ounces Annually, Is Consistent With Previous Guidance, With Offsetting Adjustments Between Mine Sites >AEM.T

12 feb. 2026, 22:15 UTC

Câștiguri

Agnico-Eagle Mines Raises Dividend to 45c >AEM.T

12 feb. 2026, 22:15 UTC

Câștiguri

Agnico-Eagle Mines 4Q Rev $3.56B >AEM.T

12 feb. 2026, 22:15 UTC

Câștiguri

Agnico-Eagle Mines 4Q EPS $3.04 >AEM.T

12 feb. 2026, 22:00 UTC

Câștiguri

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb. 2026, 22:00 UTC

Câștiguri

Agnico-Eagle Mines 4Q Rev $3.56B >AEM

12 feb. 2026, 22:00 UTC

Câștiguri

Agnico-Eagle Mines 4Q Net $1.52B >AEM

12 feb. 2026, 22:00 UTC

Câștiguri

Agnico-Eagle Mines 4Q Adj EPS $2.70 >AEM

12 feb. 2026, 22:00 UTC

Câștiguri

AGNICO EAGLE REPORTS FOURTH QUARTER AND FULL YEAR 2025 RESULTS - RECORD QUARTERLY AND ANNUAL FREE CASH FLOW; 2025 PRODUCTION GUIDANCE ACHIEVED; TOTAL 2025 SHAREHOLDER RETURNS OF $1.4 BILLION; DIVIDEND INCREASED BY 12.5%; UPDATED THREE-YEAR GUIDANCE >AEM.T

12 feb. 2026, 22:00 UTC

Câștiguri

Agnico-Eagle Mines 4Q EPS $3.04 >AEM

12 feb. 2026, 21:57 UTC

Câștiguri

XP 4Q Rev BRL4.95B >XP

12 feb. 2026, 21:52 UTC

Câștiguri

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb. 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

12 feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

12 feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 feb. 2026, 21:47 UTC

Câștiguri

Morningstar 4Q Rev $641M >MORN

12 feb. 2026, 21:39 UTC

Câștiguri

Coinbase Revenue Falls Short as Crypto Market Sags -- Barrons.com

12 feb. 2026, 21:38 UTC

Câștiguri

Howmet Stock Jumps. Earnings Show Strength For This Sector. -- Barrons.com

Comparație

Modificare preț

Odonate Therapeutics Inc Așteptări

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

EBITDA

Profit operațional

$

Despre Odonate Therapeutics Inc

Odonate, Inc., a pharmaceutical company, develops therapeutics for the treatment of cancer. It is developing tesetaxel, an orally administered chemotherapy agent, which is in Phase III clinical study for patients with metastatic breast cancer. The company was formerly known as Odonate Therapeutics, Inc. and changed its name to Odonate, Inc. in March 2023. The company was founded in 2013 and is based in New York, New York.
help-icon Live chat